SII to acquire 20% stake in IntegriMedical

IntegriMedical has developed a US patented needle-free Injection System (N-FIS) that utilises high-velocity jet stream using mechanical power to effectively and consistently administer biologics and drugs, Serum Institute of India (SII) said in a statement.

Related Keywords

United States ,India ,Australia ,Adar Poonawalla ,Sarvesh Mutha ,Serum Institute Of India ,Device Single Audit Program ,Central Drugs Standard Control Organisation ,Serum Institute ,Injection System ,Medical Device Single Audit Program ,Injections System ,Medical Managing Director Sarvesh Mutha ,